← Eichor
Study identifier: NCT06849037 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo

Condition: Meconium-stained Amniotic Fluid · Chorioamnionitis  ·  Sponsor: Western Galilee Hospital-Nahariya

PhaseNA
Planned participants182
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Our randomized controlled double blind clinical trail aims to compare maternal and neonatal infectious morbidity between women with meconium-stained amniotic fluid treated with zinacef vs. placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Maya Frank Wolf, prof.  ·  972-50-7887800  ·  mayaw@gmc.gov.il

Always discuss trial participation with your own doctor first.

Locations (1)

Galilee Medical centerNahariya, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06849037